Order the
BD Veritor™ Plus System

A customizable system that lets you pair an easy-to-use device with a selection of assays and options to simplify implementation for rapid, digital results.

 

Contact Us

 

Background Image

Prepare your order

Select the BD Veritor™ Plus Analyzer, and choose your assays and any other product options; then, you can download and send your order directly to our distributor representative. 

BD Veritor™ Plus Analyzer

BD Veritor™ Plus Analyzer

DISTRIBUTOR PRODUCT NUMBERS:

AmerisourceBergen: 10187251
Cardinal Pharmaceutical: 5531504
Concordance Healthcare Solutions: 262317
CLIA-Waived: BD-256066
Fisher: B256066
Henry Schein: 126-5527
McKesson: 1029527 / 25662409
McKesson Drug: 3934551
Medline: BDD256066
TwinMed: 005-10544

BD Product number: 256066

Quantity: 1 Analyzer

Rapid Detection of SARS-CoV-2 & Flu 
A+B** kit

Rapid Detection of SARS-CoV-2 & Flu A+B** kit

Includes: BD Veritor™ System SARS-CoV-2 & Flu A+B combined tests, sample collection swabs, BD Veritor™ System Extraction Reagent, tube trays, Positive control swabs (SARS-CoV-2, Flu A, Flu B)

 

DISTRIBUTOR PRODUCT NUMBERS:
AmerisourceBergen: 10259885
Cardinal Pharmaceutical: 5731401
CLIA-Waived: BD-256088
Fisher: B256088
Henry Schein: 1405677
McKesson: 1192774
McKesson Drug: 2341766
Medline: BDD256088

BD Product number: 256088

Quantity: 30 tests

Rapid Detection of SARS-CoV-2* kit

Rapid Detection of SARS-CoV-2* kit

Includes: BD Veritor™ System SARS-CoV-2 tests, sample collection swabs, BD Veritor™ System SARS-CoV-2 Extraction Reagent, tube tray, BD Veritor™ System SARS-CoV-2 positive (+) and negative (-) control swabs


DISTRIBUTOR PRODUCT NUMBERS:

AmerisourceBergen: 10244006
Cardinal Pharmaceutical: 5670146
Concordance Healthcare Solutions: 326088
CLIA-Waived: BD-256082
Fisher: B256082
Henry Schein: 138-4669
McKesson: 1170197 / 25602430
McKesson Drug: 1578152
Medline: BDD256082
TwinMed: 005-105445

BD Product number: 256082

Quantity: 30 tests

Rapid Detection of Flu A+B CLIA-waived kit

Rapid Detection of Flu A+B CLIA-waived kit

Includes: BD Veritor™ System Flu A+B tests, sample collection swabs, BD Veritor™ System Flu A+B Extraction Reagent, tube tray, BD Veritor™ System Flu A+B positive (+) and negative (-) control swabs


DISTRIBUTOR PRODUCT NUMBERS: 
AmerisourceBergen: 10160647
Cardinal Pharmaceutical: 5383567
Concordance Healthcare Solutions: 201503
CLIA-Waived: BD-256045
Fisher: B256045
Henry Schein: 992-0002
McKesson: 785953 / 59532400
McKesson Drug: 3491560
Medline: BDD256045

BD Product number: 256045

Quantity: 30 tests

Rapid Detection of Flu A+B kit

Rapid Detection of Flu A+B kit

Includes: BD Veritor™ System Flu A+B tests, sample transfer pipettes, BD Veritor™ System Flu A+B Extraction Reagent, tube tray, BD Veritor™ System Flu A+B positive (+) and negative (-) control swabs

DISTRIBUTOR PRODUCT NUMBERS:

Fisher: B256041
Henry Schein: 9920004
McKesson: 826356
Medline: BDD256041

BD Product number: 256041

Quantity: 30 tests

Rapid Detection of Group A Strep CLIA-waived kit

Rapid Detection of Group A Strep CLIA-waived kit

Includes: BD Veritor™ System Group A Strep devices, BD GAS Reagent 1, BD GAS Reagent 2, sterile sampling swabs, BD Veritor™ System GAS positive (+) and negative (-) control swabs

DISTRIBUTOR PRODUCT NUMBERS:
AmerisourceBergen: 10160653
Cardinal Pharmaceutical: 5358981
Concordance Healthcare Solutions: 223232
CLIA-Waived: BD-256040
Fisher: B256040
McKesson: 879630 / 56652400
McKesson Drug: 3491578
Medline: BDD256040

BD Product number: 256040

Quantity: 30 tests

Rapid Detection of RSV CLIA-waived kit

Rapid Detection of RSV CLIA-waived kit

Includes: BD Veritor™ System RSV tests, sample collection swabs, BD Veritor™ System RSV Extraction Reagent, tube tray, BD Veritor™ System RSV positive (+) and negative (-) control swabs

DISTRIBUTOR PRODUCT NUMBERS:
AmerisourceBergen: 10160687
Concordance Healthcare Solutions: 223383
CLIA-Waived: BD-256038
Fisher: B256038
McKesson: 879803 / 60382400
McKesson Drug: 3491586
Medline: BDD256038

BD Product number: 256038

Quantity: 30 tests

Rapid Detection of RSV kit

Rapid Detection of RSV kit

Includes: BD Veritor™ System RSV tests, sample transfer pipettes, BD Veritor™ System RSV Extraction Reagent, tube tray, BD Veritor™ System RSV positive (+) and negative (-) control swabs

DISTRIBUTOR PRODUCT NUMBERS:
Fisher: B256042
Henry Schein: 9920005
McKesson: 821408
Medline: BDD256042

BD Product number: 256042

Quantity: 30 tests

BD InfoWiFi module

BD InfoWiFi module

Barcode scanning + downloadable reporting

  • Clearly displayed result on Analyzer
  • Option to integrate into BD Synapsys™ Informatics Solution and wirelessly transmit results
  • Scan patient/user/kit barcodes
  • Printed record of result*
  • Downloadable CSV file of result

Suggested products:

In addition to the BD Veritor™ Plus System, if you want to print results, you will need to purchase a compatible compatible Epson® receipt and label printer and a compatible USB printer cable.*
*Additional purchase necessary

BD Product number: 445010

Quantity: 1 Unit

USB printer cable

USB printer cable

DISTRIBUTOR PRODUCT NUMBERS:
Medline: BDD443907
McKesson: 1029529
TwinMed: 005-105451
Concordance Healthcare Solutions: 329327
Fisher: B443907

BD Product number: 443907

Quantity: 1 Unit

BD Synapsys™ Informatics Solution

BD Synapsys™ Informatics Solution

BD Synapsys™ Informatics Solution provides secure, scalable and automated result reporting to help eliminate manual data entry, expedite decision making, and allow clinicians to focus on patient care. It is a robust, scalable and secure solution that offers automated result reporting to the LIS and EMR, streamlined public health reporting, and access to analytics and dashboards to drive operational decision-making. Service agreement is required.

BD Product number: 440141

Quantity:

Happy with your selections?

Download a copy to have handy for when you contact your distributer representative.

Selected products:

None

 

Contact your Distributor to place your order

Contact your distributor or call our sales department to purchase. Not sure which distributor to order from? We can help!

DistributorPhone number
AmerisourceBergen(610) 727-7000
Cardinal Pharmaceutical(800) 926-3161
Concordance Healthcare Solutions(800) 447-0225
CLIA-Waived(858) 481-5031
Fisher (800) 640-0640
Henry Schein(800) 772-4346
McKesson(800) 654-7240
McKesson Drug(866) 329-0113
Medline(800) 633-5463
TwinMed(877) 894-6633

 

If your facility needs additional testing equipment or supplies, please reach out to a BD distributor partner.

To order BD™ Synapsys Informatics Solution, call 800-638-6663.

Contact a Sales Representative to get your organization’s

diagnostic testing program started today

BD Veritor™ Plus System Support & Training

See how BD supports you with tools, education, and training—enabling a streamlined point-of-care experience for those you serve, and confidence in your results.

Professional Care Testing

The BD Veritor™ Plus System enhances point-of-care testing for SARS-CoV-2,* Flu A+B, RSV, and Group A Strep assays, providing rapid diagnostic testing in a convenient, portable instrument.

* The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.

This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA for use by authorized laboratories.

RSV=respiratory syncytial virus; SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.

This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.

This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.

 Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C §263a, that meet the requirements to perform moderate, high or waived complexity tests.  This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.